208 related articles for article (PubMed ID: 27096255)
21. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
22. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
Whop LJ; Baade P; Garvey G; Cunningham J; Brotherton JM; Lokuge K; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig DM; Moore SP; Condon JR
PLoS One; 2016; 11(4):e0150473. PubMed ID: 27064273
[TBL] [Abstract][Full Text] [Related]
23. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
[TBL] [Abstract][Full Text] [Related]
24. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
25. Cervical carcinoma in a Muslim community.
Badar F; Anwar N; Meerza F; Sultan F
Asian Pac J Cancer Prev; 2007; 8(1):24-6. PubMed ID: 17477766
[TBL] [Abstract][Full Text] [Related]
26. A case of coexistent poorly differentiated adenosquamous carcinoma (glassy cell carcinoma), usual-type adenocarcinoma, and squamous cell carcinoma in situ of the cervix.
Habara K; Nishikori A; Kiyama J; Nakashima M; Koda M; Sasaki K; Sakashita T; Tanaka N; Yonehara S
Med Mol Morphol; 2023 Sep; 56(3):217-224. PubMed ID: 37129713
[TBL] [Abstract][Full Text] [Related]
27. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
Macgregor JE; Campbell MK; Mann EM; Swanson KY
BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
[TBL] [Abstract][Full Text] [Related]
28. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia.
Stockton D; Cooper P; Lonsdale RN
J Med Screen; 1997; 4(1):40-3. PubMed ID: 9200062
[TBL] [Abstract][Full Text] [Related]
29. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer: prevention and treatment.
Denny L
Discov Med; 2012 Aug; 14(75):125-31. PubMed ID: 22935209
[TBL] [Abstract][Full Text] [Related]
31. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study.
Landy R; Pesola F; Castañón A; Sasieni P
Br J Cancer; 2016 Oct; 115(9):1140-1146. PubMed ID: 27632376
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
Othman NH; Devi BC; Halimah Y
Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
[TBL] [Abstract][Full Text] [Related]
33. Negative Roche cobas HPV testing in cases of biopsy-proven invasive cervical carcinoma, compared with Hybrid Capture 2 and liquid-based cytology.
Vasilyeva D; Tiscornia-Wasserman P; Gonzalez AA
J Am Soc Cytopathol; 2021; 10(2):128-134. PubMed ID: 32896510
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of patients operated for adenocarcinoma and adenosquamous carcinoma of uterine cervix].
Sobol A; Emerich J; Kobierski J; Lapińska S; Stankowska B; Starnawski M
Ginekol Pol; 1999 Feb; 70(2):75-80. PubMed ID: 10349811
[TBL] [Abstract][Full Text] [Related]
35. Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
Castañón A; Landy R; Cuzick J; Sasieni P
PLoS Med; 2014 Jan; 11(1):e1001585. PubMed ID: 24453946
[TBL] [Abstract][Full Text] [Related]
36. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence.
Zappa M; Visioli CB; Ciatto S; Iossa A; Paci E; Sasieni P
Br J Cancer; 2004 May; 90(9):1784-6. PubMed ID: 15150597
[TBL] [Abstract][Full Text] [Related]
37. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
38. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.
Vizcaino AP; Moreno V; Bosch FX; Muñoz N; Barros-Dios XM; Parkin DM
Int J Cancer; 1998 Feb; 75(4):536-45. PubMed ID: 9466653
[TBL] [Abstract][Full Text] [Related]
39. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire.
Herbert A; Singh N; Smith JA
Cytopathology; 2001 Feb; 12(1):26-36. PubMed ID: 11256934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
